Sign In
Buy NVAX
$10.20
-0.0100 (-0.0979%)
At Close: Jun 03, 2026
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It
10:01am, Wednesday, 22'nd Jan 2025
Novavax (NVAX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Novavax (NVAX) Rises But Trails Market: What Investors Should Know
06:51pm, Wednesday, 15'th Jan 2025
In the latest trading session, Novavax (NVAX) closed at $8.55, marking a +0.53% move from the previous day.
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know
10:01am, Wednesday, 08'th Jan 2025
Recently, Zacks.com users have been paying close attention to Novavax (NVAX). This makes it worthwhile to examine what the stock has in store.
Here's why vaccine stocks are surging in 2025
08:31am, Wednesday, 08'th Jan 2025
After undergoing years of stock market decline as reporting and awareness about the COVID-19 pandemic subsided, major vaccine stocks received a major, if grim, boost in early 2025.
Vaccine Stocks Jump After CDC Reports First US Bird-Flu Death
07:56am, Wednesday, 08'th Jan 2025
The first bird-flu fatality in the United States sparks investor interest in several vaccine makers that are developing experimental H5N1 vaccines.
Strength Seen in Novavax (NVAX): Can Its 10.9% Jump Turn into More Strength?
07:10am, Wednesday, 08'th Jan 2025
Novavax (NVAX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the roa
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It
10:01am, Tuesday, 24'th Dec 2024
Recently, Zacks.com users have been paying close attention to Novavax (NVAX). This makes it worthwhile to examine what the stock has in store.
Novavax Advances Corporate Growth Strategy Through Sanofi Partnership, Including Achievement of First $50 Million Milestone
08:00am, Friday, 13'th Dec 2024
Novavax continues to progress Sanofi agreement by achieving first milestone, with additional milestones and ongoing tiered royalties to come, solidifying a strong model for future partnerships Novavax
Why Is Novavax (NVAX) Up 13.6% Since Last Earnings Report?
12:36pm, Thursday, 12'th Dec 2024
Novavax (NVAX) reported earnings 30 days ago. What's next for the stock?
NVAX Starts Late-Stage Study on COVID-19-Flu Combo & Flu Vaccines
08:50am, Wednesday, 11'th Dec 2024
Novavax is working with the FDA to explore a pathway for accelerated approval of the COVID-19-flu combination and standalone flu vaccines.
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know
10:05am, Tuesday, 10'th Dec 2024
Novavax (NVAX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Novavax Initiates Phase 3 Trial for COVID-19-Influenza Combination and Stand-Alone Influenza
08:00am, Tuesday, 10'th Dec 2024
Company continuing to work with the U.S. FDA on potential for accelerated approval pathway Novavax intends to partner on both candidates to advance to filing and commercialization GAITHERSBURG, Md. ,
Novavax to Sell Czech Manufacturing Plant to Novo Nordisk for $200M
12:55pm, Thursday, 05'th Dec 2024
NVAX intends to use the payment from Novo to advance the development of its vaccine pipeline. The deal is expected to be closed by the end of this year.
2 Beaten-Down "Pandemic Stocks" to Consider for Contrarian Investors
05:30am, Thursday, 05'th Dec 2024
Many companies that performed well in the early pandemic years have since fallen off the radar or at least have seen their shares drop substantially during the past three years. Telemedicine Teladoc H
Novavax to sell Czech manufacturing unit to Novo Nordisk for $200 mln
03:03am, Wednesday, 04'th Dec 2024
COVID-19 vaccine maker Novavax said on Wednesday it will sell its manufacturing facility in Czech Republic to Wegovy-maker Novo Nordisk for $200 million and use the proceeds for its vaccine pipeline.
